Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 20/20 | 0.57 |
| ▸ | ITGA2B | P08514 | 20/20 | 0.57 |
| ▸ | F2R | P25116 | 11/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7501492 | 0.99 | ITGB3 (0.56) | ITGB3ITGA2BF2R | |
| Hydrochloric Acid SCHEMBL7499246 | 0.84 | ITGB3 (0.59) | ITGB3ITGA2BF2R | |
| SCHEMBL27447972 | 0.84 | ITGB3 (0.56) | ITGB3ITGA2BF2R | |
| Hydrochloric Acid SCHEMBL7502044 | 0.83 | ITGB3 (0.64) | ITGB3ITGA2BF2R | |
| Hydrochloric Acid SCHEMBL7494246 | 0.82 | ITGB3 (0.55) | ITGB3ITGA2BF2R | |
| Hydrochloric Acid SCHEMBL7818066 | 0.81 | ITGB3 (0.56) | ITGB3ITGA2BF2R | |
| Hydrochloric Acid SCHEMBL7500169 | 0.81 | ITGB3 (0.62) | ITGB3ITGA2BF2R | |
| Hydrochloric Acid SCHEMBL7817873 | 0.80 | ITGB3 (0.54) | ITGB3ITGA2BF2R | |
| SCHEMBL7494542 | 0.80 | ALDH1A1 (0.45) | ITGB3ITGA2BF2R | |
| Hydrochloric Acid SCHEMBL7503794 | 0.79 | ITGB3 (0.53) | ITGB3ITGA2BF2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010051730-A1 | Beta-alanine derivative and a process for the preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010051730-A1 | Beta-alanine derivative and a process for the preparation thereof | F13B, FGB, TGFB1 | ITGB3 52/4885ITGA2B 14/4885F2R 234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.